RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      How a VOICE for clinical pharmacology turns into a RECIPE for its development

      한글로보기

      https://www.riss.kr/link?id=A106848500

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Pharmacology is the study of the actions of synthetic or semisynthetic chemicals or naturally occurring substances on molecules, cells, tissues, and living organisms, as seen in physiological and pathological systems, seeking to establish order, patte...

      Pharmacology is the study of the actions of synthetic or semisynthetic chemicals or naturally occurring substances on molecules, cells, tissues, and living organisms, as seen in physiological and pathological systems, seeking to establish order, pattern, and sequence among them, aiming ultimately to determine the rules by which pathophysiological information can be coded into molecules, allowing prediction of both beneficial and harmful consequences. Clinical pharmacology is the application, informed by an understanding of pharmacology, of all aspects of the study and use of medicines in humans, whose practitioners, normally medically qualified, teach, do research, frame policy, and give information and advice about the actions and proper uses of medicines in humans and implement that knowledge in clinical practice. Clinical pharmacology expanded in the UK during the 1960s and 1970s and maintained a steady state during the 1980s, but thereafter started to decline. Since 2006 this decline has been halted and partly reversed through the efforts of the British Pharmacological Society, by demonstrating the need for clinical pharmacology in clinical practice, teaching, research, and policy making, and bringing that need to the attention of medical colleagues, regulators, government, and the public. Efforts continue to maintain and enhance this recovery, using the VOICE paradigm, which involves improving and maintaining the Visibility of the specialty, Outreach to advertise its attractiveness to potential trainees and creating a public image for the specialty, Integration with other disciplines, encouraging Coverage of neglected areas, and the use of Emissaries, particularly younger members of the discipline, to promote it, both within medicine and in the wider world. Fortuitously, translation of the five elements of this paradigm into Korean, and back-translation into English, with the addition of a sixth element, provides a RECIPE for the future of clinical pharmacology and therapeutics.

      더보기

      참고문헌 (Reference)

      1 Mroz A, "let’s find out if it will fly"

      2 Aronson J, "When I use a word ... Materia medica, clinical pharmacology, and therapeutics" 103 : 361-363, 2010

      3 Laurence D, "What is pharmacology? A discussion" 18 : 153-155, 1997

      4 Aronson JK, "Towards a single VOICE for European clinical pharmacology: proposals for future developments" 69 : 1981-1984, 2013

      5 Black JW, "TiPS on identity" 17 : 121-, 1996

      6 Tomlinson S, "The research assessment exercise and medical research" 320 : 636-639, 2000

      7 "The image of clinical pharmacology" 295 : 129-, 1970

      8 Reidenberg MM, "The history of Clinical Pharmacology & Therapeutics" 47 : 277-279, 1990

      9 British Pharmacological Society, "The Society publishes "Clinical Pharmacology: A dynamic medical speciality essential for UK Healthcare""

      10 Banatvala J, "The Research Assessment Exercise is bad for UK medicine" 365 : 458-460, 2005

      1 Mroz A, "let’s find out if it will fly"

      2 Aronson J, "When I use a word ... Materia medica, clinical pharmacology, and therapeutics" 103 : 361-363, 2010

      3 Laurence D, "What is pharmacology? A discussion" 18 : 153-155, 1997

      4 Aronson JK, "Towards a single VOICE for European clinical pharmacology: proposals for future developments" 69 : 1981-1984, 2013

      5 Black JW, "TiPS on identity" 17 : 121-, 1996

      6 Tomlinson S, "The research assessment exercise and medical research" 320 : 636-639, 2000

      7 "The image of clinical pharmacology" 295 : 129-, 1970

      8 Reidenberg MM, "The history of Clinical Pharmacology & Therapeutics" 47 : 277-279, 1990

      9 British Pharmacological Society, "The Society publishes "Clinical Pharmacology: A dynamic medical speciality essential for UK Healthcare""

      10 Banatvala J, "The Research Assessment Exercise is bad for UK medicine" 365 : 458-460, 2005

      11 Dollery CT, "Report on the development of clinical pharmacology" 80 : 222-223, 1974

      12 Laurence DR, "Quantitative Methods in Human Pharmacology and Therapeutics" Pergamon Press 1959

      13 Jané F, "Professional prospects in clinical pharmacology. History and present situation in Spain" 18 (18): 5-7, 1996

      14 Maxwell SR, "Prescribing safety: ensuring that new graduates are prepared" 385 : 579-581, 2015

      15 Shelley JH, "Paul Martini: the first clinical pharmacologist?" 353 : 1870-1873, 1999

      16 "Oxford English Dictionary"

      17 Aagaard GN, "Ninety years of therapeutics: a history of the American Society for Clinical Pharmacology and Therapeutics" 47 : 247-304, 1990

      18 Williams G, "Misleading, unscientific, and unjust: the United Kingdom’s re-search assessment exercise" 316 : 1079-1082, 1998

      19 Martini P, "Methodenlehre der Therapeutischen Untersuchung" Springer Verlag 1932

      20 Aronson JK, "Medication errors: definitions and classification" 67 : 599-604, 2009

      21 Uvnäs B, "Klinisk farmakologi (6): utvecklingen i Sverige" 67 : 1918-1922, 1970

      22 Spechtmeyer H, "Klinische Pharmakologie in den USA. I. Entwicklung der klinischen Pharmakologie" 35 : 1833-1837, 1968

      23 Welsh Government, "Investing to save 3: Short-term investment for long-term benefit"

      24 Aronson JK, "Integrating pharmacology and clinical pharmacology" 71 : 787-790, 2011

      25 Collini S, "Impact on humanities"

      26 Kampffmeyer H, "Impact of the West German drug law upon development of clinical pharmacology" 16 : 616-619, 1974

      27 Miller RR, "History of clinical pharmacy and clinical pharmacology" 21 : 195-197, 1981

      28 Sang-GooShin, "History of clinical pharmacology in Korea" 대한임상약리학회 22 (22): 43-51, 2014

      29 Montastruc P, "Histoire de la pharmacologie clinique en France: dans une scintillante introspective, l'adaptation, l'évaluation, la défense et l'illustra-tion du médicament en France 1978-1981" 69 : 481-482, 2014

      30 Aronson JK, "Finding a VOICE for UK clinical pharmacology" 73 : 843-845, 2012

      31 Naranjo CA, "Farmacologia clinica en Chile: estado actual y desarrollo futuro" 106 : 165-169, 1978

      32 Brainerd HD, "Estudios sobre la farmacología clínica de Aureomicina" 59 : 14-20, 1952

      33 Sjöqvist F, "Development of clinical pharmacology as a medical speciality in Europe–the roles of WHO, IUPHAR and EACPT" 115 : 172-178, 2014

      34 Igić R, "Contribution to the history of clinical pharmacology in former Yugoslavia" 64 : 573-574, 2007

      35 Kshirsagar N, "Clinical pharmacology: prospects and development in India" 43 : 489-491, 2011

      36 Lasagna L, "Clinical pharmacology: present status and future development" 152 : 388-391, 1966

      37 Maxwell SR, "Clinical pharmacology--too young to die?" 367 : 799-800, 2006

      38 Birkett D, "Clinical pharmacology in research, teaching and health care. Considerations by IUPHAR, the International Union of Basic and Clinical Pharmacology" 107 : 531-559, 2010

      39 Zagorodnikova Goryachkina K, "Clinical pharmacology in Russia–historical development and current state" 71 : 159-163, 2015

      40 Aronson JK, "Clinical pharmacology and therapeutics in the UK–a great instauration" 69 : 111-117, 2010

      41 Gaddum JH, "Clinical pharmacology" 47 : 195-204, 1954

      42 British Pharmacological Society, "Clinical Pharmacology: a Dynamic Medical Speciality Essential for UK Healthcare"

      43 Reynolds LA, "Clinical Pharmacology in the UK, c. 1950–2000: Influences and Institutions" The Wellcome Trust Centre for the History of Medicine 2008

      44 British Pharmacological Society, "British Pharmacological Society Ambassadors"

      45 Heath G, "An evolution of drug development and clinical pharmacology during the 20th century" 40 : 918-929, 2000

      46 Martin JH, "Achieving the World Health Organization's vision for clinical pharmacology" 81 : 223-227, 2016

      47 Morgan JP, "Academic clinical pharmacology: development, current and future status" 15 : 725-730, 1975

      48 Pirmohamed M, "A prescription for the NHS. Recognising the value of clinical pharmacology and therapeutics"

      49 Aronson JK, "A manifesto for clinical pharmacology from principles to practice" 70 : 3-13, 2010

      50 Gaw A, ""The principles of a future pharmacology": Johann Christian Reil (1759-1813) and his role in the development of clinical pharmacology" 72 : 13-17, 2016

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2014-12-23 학술지명변경 한글명 : 임상약리학회지 -> Translational and Clinical Pharmacology
      외국어명 : The Journal of Korean Society for Clinical Pharmacology and Therapeutics -> Translational and Clinical Pharmacology
      KCI등재
      2013-10-01 평가 등재학술지 선정 (기타) KCI등재
      2011-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2007-01-01 평가 SCOPUS 등재 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.07 0.07 0.05
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.05 0.05 0.3 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼